Life Sciences
Create Health Ventures will focus on funding early-stage digital health companies led by founders with healthcare backgrounds.
ReviR Therapeutics secures $30 million for its drug discovery platform. RetiSpec raises $10 million for its eye-diagnostics offering. SoundHealth scores $7 million for its acoustics medical device for nasal congestion.
Sanofi head of organization capability and transformation, Felix Lee, discusses how the pharma giant leverages digital therapeutics company DarioHealth to complement its drug offerings and enhance patient care and self-management.
Scopio Labs secured $42 million in Series D funding, and robotics company NAVIGANTIS closed a $12 million Series A round.
The platform includes language support, call-to-text functionality, a high degree of automation and community outreach features.
Duke-NUS Medical School's LIVE Ventures will bring together scientists and public and private sector entities to commercialize academic research concepts.
Also, a Hong Kong project has received $5 million in funding to develop LLM-run companion robots for the mentally underserved.
The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.
The funding will be used to secure FDA clearance for its benchtop blood-testing system for use in doctor's offices, clinics and pharmacies.
HIMSS24
Emmanuel Bilbault, cofounder and CEO of POSOS, says the company's AI-driven international drug database's use of medication codes enables it to cross-reference EHR data and tailor prescriptions to meet a patient's specific needs.